- Home
- KRMD vs PLL Comparison
KRMD vs PLL Comparison
Compare KRMD & PLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- PLL
- Stock Information
- Founded
- KRMD 1980
- PLL 2016
- Country
- KRMD United States
- PLL United States
- Employees
- KRMD N/A
- PLL N/A
- Industry
- KRMD Medical/Dental Instruments
- PLL Other Metals and Minerals
- Sector
- KRMD Health Care
- PLL Basic Materials
- Exchange
- KRMD Nasdaq
- PLL Nasdaq
- Market Cap
- KRMD 126.9M
- PLL N/A
- IPO Year
- KRMD N/A
- PLL 2017
- Fundamental
- Price
- KRMD $3.29
- PLL $7.32
- Analyst Decision
- KRMD Strong Buy
- PLL Hold
- Analyst Count
- KRMD 4
- PLL 6
- Target Price
- KRMD $4.63
- PLL $11.92
- AVG Volume (30 Days)
- KRMD 118.8K
- PLL 269.0K
- Earning Date
- KRMD 05-07-2025
- PLL 05-07-2025
- Dividend Yield
- KRMD N/A
- PLL N/A
- EPS Growth
- KRMD N/A
- PLL N/A
- EPS
- KRMD N/A
- PLL N/A
- Revenue
- KRMD $35,083,740.00
- PLL $106,472,000.00
- Revenue This Year
- KRMD $16.50
- PLL $8.92
- Revenue Next Year
- KRMD $15.47
- PLL $26.12
- P/E Ratio
- KRMD N/A
- PLL N/A
- Revenue Growth
- KRMD 19.65
- PLL 100.07
- 52 Week Low
- KRMD $1.86
- PLL $5.15
- 52 Week High
- KRMD $5.05
- PLL $16.59
- Technical
- Relative Strength Index (RSI)
- KRMD 71.25
- PLL 51.48
- Support Level
- KRMD $2.51
- PLL $7.44
- Resistance Level
- KRMD $2.86
- PLL $7.57
- Average True Range (ATR)
- KRMD 0.19
- PLL 0.57
- MACD
- KRMD 0.09
- PLL -0.03
- Stochastic Oscillator
- KRMD 96.12
- PLL 34.25
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).